Shareholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Ordinary Share Capital

Ordinary share capital is composed as follows:

	December 31, 2022				June 30, 2023 (unaudited)
	Authorized		Issued and outstanding		Authorized		Issued and outstanding
	Number of shares
Ordinary shares of no-par value		362,116,800		69,105,000		362,116,800		69,373,135

Schedule of Options and Changes

A summary of the status of options under the Plan as of June 30, 2023 and changes during the relevant period ended on that date is presented below:

	Six months ended June 30, 2023 (unaudited)
	Number of options			Weighted average exercise price		Aggregate intrinsic value		Weighted average remaining contractual life (years)
Outstanding at beginning of period		8,237,794		$	5.8	$	2,588		7.24
Granted		3,185,111		$	3.4
Exercised		(2,500	)	$	1.1
Forfeited and cancelled		(41,292	)	$	9.9
Outstanding at end of period		11,379,113		$	5.1	$	7,709		7.5
Exercisable options		5,838,956		$	4.5	$	4,934		5.9

Schedule of the Status of RSUs

A summary of the status of RSUs under the Plan as of June 30, 2023 and changes during the relevant period ended on that date is presented below:

	Number of RSU
Outstanding at beginning of year		924,867
Granted		391,724
Forfeited and cancelled		(12,820	)
Vested		(197,738	)
Outstanding on June 30, 2023		1,106,033

Schedule of Total Equity-Based Compensation Expense

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the six months ended June 30, 2022 and 2023, was comprised as follows:

	Six months ended June 30,
	2022		2023
	Unaudited
Research and development	$	2,260	$	2,536
Marketing expenses		60		202
General and administrative		1,125		1,046
Total share-based compensation expense	$	3,445	$	3,784